Insider / ARCH CAPITAL GROUP LTD.
Posner Brian S
Director at ARCH CAPITAL GROUP LTD.
- Company
- ARCH CAPITAL GROUP LTD.
- Ticker
- ACGL
- First filing on record
- May 7, 2026
- Latest trade on record
- June 3, 2026
- SEC filings
- EDGAR ↗
Posner Brian S, Director at ARCH CAPITAL GROUP LTD., has disclosed 3 transactions in ACGL since May 7, 2026: 0 purchases (0 open-market buys) and 2 sales, worth about $93K at the reported prices. The latest was filed June 4, 2026, 1 day after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Posner Brian S made no purchases and 2 sales worth $93K, plus 1 other transaction. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Posner Brian S has traded 1 stock on record; the largest by dollars is ACGL.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| S | Open-market sale | 2 | 5,000 | $93K |
| A | Grant or award | 1 | 2,071 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 3 | 0 | 2 · $93K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ACGL | Sell S | June 3, 2026 | June 4, 2026 | 1d | 3,000 | $20 | $59K | Form 4 ↗ | ||
| ACGL | Sell S | May 11, 2026 | May 12, 2026 | 1d | 2,000 | $17 | $34K | Form 4 ↗ | ||
| ACGL | Other A | May 5, 2026 | May 7, 2026 | 2d | 2,071 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| June 4, 2026 | Form 4 | 0001372455-26-000008 | 1 | published | EDGAR ↗ |
| May 12, 2026 | Form 4 | 0001372455-26-000006 | 1 | published | EDGAR ↗ |
| May 7, 2026 | Form 4 | 0001372455-26-000004 | 1 | published | EDGAR ↗ |
Other insiders at ARCH CAPITAL GROUP LTD.
- Morin Francois CFO and Treasurer 3 rows
- Houston Daniel Joseph Director 2 rows
- KILCOYNE MOIRA A. Director 2 rows
- MALLESCH EILEEN A Director 2 rows
- PASQUESI JOHN M Director 2 rows
- Triplett Neal F Director 2 rows
- MOCZARSKI ALEXANDER S Director 1 row
Everyone on file, with contracts and lobbying under the company's name: ARCH CAPITAL GROUP LTD..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 3 | May 7, 2026 | June 4, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.